KR

Kalind Rastogi

Active Director Director DIN 09357827
DIN 09357827 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Kalind Rastogi

Data last updated:

Kalind Rastogi is a Director at Vigilan Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Vigilan Pharmaceuticals Private Limited reported revenue of ₹16.1 Lakh (FY 2024).

DIN 09357827
Primary Designation Director
Industry Chemicals
First Appointment 13 Oct 2021
Oldest Company Age 5 yrs
Largest company Vigilan Pharmaceuticals Private Limited · ₹16.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Oct 20212021₹16.1 Lakh (FY 2024)Active

Board colleagues of Kalind Rastogi

Directorship timeline

Open interactive timeline →
Vigilan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kalind Rastogi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalind Rastogi

Kalind Rastogi currently holds 1 directorship: Vigilan Pharmaceuticals Private Limited (Director, since 13 Oct 2021, revenue ₹16.1 Lakh (FY 2024)).

Kalind Rastogi was first appointed on 13 Oct 2021 as Director at Vigilan Pharmaceuticals Private Limited.

The current boards of Kalind Rastogi's companies include Ram Krishna Rastogi (Vigilan Pharmaceuticals Private Limited), Shyam Rastogi (Vigilan Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available